Guerbet SA GBT.PA Stock
Guerbet SA Price Chart
Guerbet SA GBT.PA Financial and Trading Overview
Guerbet SA stock price | 33.5 EUR |
Previous Close | 16.88 EUR |
Open | 16.96 EUR |
Bid | 0 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 16.9 - 17.6 EUR |
52 Week Range | 15.28 - 23.8 EUR |
Volume | 5.53K EUR |
Avg. Volume | 11.85K EUR |
Market Cap | 221.33M EUR |
Beta (5Y Monthly) | 0.686206 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 1.75 EUR |
Forward Dividend & Yield | 0.85 (4.99%) |
Ex-Dividend Date | July 1, 2022 |
1y Target Est | 18.8 EUR |
GBT.PA Valuation Measures
Enterprise Value | 483.64M EUR |
Trailing P/E | N/A |
Forward P/E | 5.3313074 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.28762522 |
Price/Book (mrq) | 0.5831699 |
Enterprise Value/Revenue | 0.629 |
Enterprise Value/EBITDA | 4.849 |
Trading Information
Guerbet SA Stock Price History
Beta (5Y Monthly) | 0.686206 |
52-Week Change | -24.97% |
S&P500 52-Week Change | 20.43% |
52 Week High | 23.8 EUR |
52 Week Low | 15.28 EUR |
50-Day Moving Average | 17.07 EUR |
200-Day Moving Average | 17.53 EUR |
GBT.PA Share Statistics
Avg. Volume (3 month) | 11.85K EUR |
Avg. Daily Volume (10-Days) | 5.38K EUR |
Shares Outstanding | 12.62M |
Float | 3.84M |
Short Ratio | N/A |
% Held by Insiders | 56.18% |
% Held by Institutions | 13.42% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.5 |
Trailing Annual Dividend Yield | 2.96% |
5 Year Average Dividend Yield | 256.00% |
Payout Ratio | N/A |
Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -5.34% |
Operating Margin (ttm) | 5.05% |
Gross Margin | 73.50% |
EBITDA Margin | 12.96% |
Management Effectiveness
Return on Assets (ttm) | 2.50% |
Return on Equity (ttm) | -10.47% |
Income Statement
Revenue (ttm) | 769.5M EUR |
Revenue Per Share (ttm) | 60.87 EUR |
Quarterly Revenue Growth (yoy) | 6.50% |
Gross Profit (ttm) | N/A |
EBITDA | 99.74M EUR |
Net Income Avi to Common (ttm) | -41116000 EUR |
Diluted EPS (ttm) | -3.22 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 41.68M EUR |
Total Cash Per Share (mrq) | 3.3 EUR |
Total Debt (mrq) | 312.04M EUR |
Total Debt/Equity (mrq) | 82.21 EUR |
Current Ratio (mrq) | 2.127 |
Book Value Per Share (mrq) | 30.077 |
Cash Flow Statement
Operating Cash Flow (ttm) | 30.44M EUR |
Levered Free Cash Flow (ttm) | -52361376 EUR |
Profile of Guerbet SA
Country | France |
State | N/A |
City | Villepinte |
Address | 15, rue des Vanesses |
ZIP | 93420 |
Phone | 33 1 45 91 50 00 |
Website | https://www.guerbet.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 2839 |
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was incorporated in 1926 and is headquartered in Villepinte, France.
Q&A For Guerbet SA Stock
What is a current GBT.PA stock price?
Guerbet SA GBT.PA stock price today per share is 33.5 EUR.
How to purchase Guerbet SA stock?
You can buy GBT.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Guerbet SA?
The stock symbol or ticker of Guerbet SA is GBT.PA.
Which industry does the Guerbet SA company belong to?
The Guerbet SA industry is Medical Devices.
How many shares does Guerbet SA have in circulation?
The max supply of Guerbet SA shares is 12.58M.
What is Guerbet SA Price to Earnings Ratio (PE Ratio)?
Guerbet SA PE Ratio is 19.14285700 now.
What was Guerbet SA earnings per share over the trailing 12 months (TTM)?
Guerbet SA EPS is 1.75 EUR over the trailing 12 months.
Which sector does the Guerbet SA company belong to?
The Guerbet SA sector is Healthcare.
Guerbet SA GBT.PA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
CAC Mid & Small MS190 | 14267.59 EUR 15596.4 USD |
-0.38
|
— — | — — | — — | — - | — — |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
CAC Small CS90 | 11739.13 EUR 12832.46 USD |
-0.74
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}